American International Group, Inc. Jounce Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.9 - $1.85 $364 - $749	405 Added 2.03%	20,337 $37,000
Q4 2022 Feb 10, 2023	SELL	$0.64 - $1.99 $46 - $143	-72 Reduced 0.36%	19,932 $22,000
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $769 - $1,387	282 Added 1.43%	20,004 $47,000
Q2 2022 Aug 12, 2022	BUY	$2.8 - $7.67 $9,394 - $25,732	3,355 Added 20.5%	19,722 $60,000
Q1 2022 May 13, 2022	SELL	$6.01 - $8.54 $6,923 - $9,838	-1,152 Reduced 6.58%	16,367 $111,000
Q4 2021 Feb 11, 2022	SELL	$7.11 - $9.64 $3,725 - $5,051	-524 Reduced 2.9%	17,519 $146,000
Q3 2021 Nov 12, 2021	SELL	$5.04 - $8.73 $2,162 - $3,745	-429 Reduced 2.32%	18,043 $134,000
Q2 2021 Aug 13, 2021	BUY	$6.58 - $10.66 $55,370 - $89,703	8,415 Added 83.67%	18,472 $126,000
Q1 2021 May 07, 2021	BUY	$6.73 - $13.87 $181 - $374	27 Added 0.27%	10,057 $103,000
Q4 2020 Feb 12, 2021	SELL	$6.37 - $10.33 $1,834 - $2,975	-288 Reduced 2.79%	10,030 $70,000
Q3 2020 Nov 04, 2020	SELL	$4.58 - $10.95 $1,076 - $2,573	-235 Reduced 2.23%	10,318 $84,000
Q2 2020 Aug 12, 2020	BUY	$4.17 - $7.58 $4,065 - $7,390	975 Added 10.18%	10,553 $73,000
Q1 2020 May 04, 2020	SELL	$2.91 - $8.7 $1,612 - $4,819	-554 Reduced 5.47%	9,578 $45,000
Q4 2019 Feb 05, 2020	SELL	$2.81 - $9.21 $236 - $773	-84 Reduced 0.82%	10,132 $88,000
Q3 2019 Nov 08, 2019	SELL	$3.33 - $4.93 $239 - $354	-72 Reduced 0.7%	10,216 $34,000
Q2 2019 Aug 13, 2019	BUY	$4.3 - $6.73 $1,006 - $1,574	234 Added 2.33%	10,288 $51,000
Q1 2019 May 06, 2019	SELL	$3.43 - $6.87 $1,118 - $2,239	-326 Reduced 3.14%	10,054 $62,000
Q4 2018 Feb 13, 2019	SELL	$2.69 - $6.71 $215 - $536	-80 Reduced 0.76%	10,380 $35,000
Q3 2018 Nov 09, 2018	BUY	$6.5 - $8.37 $1,228 - $1,581	189 Added 1.84%	10,460 $68,000
Q2 2018 Aug 08, 2018	BUY	$7.27 - $21.88 $7,400 - $22,273	1,018 Added 11.0%	10,271 $79,000
Q1 2018 May 07, 2018	SELL	$13.4 - $28.4 $6,686 - $14,171	-499 Reduced 5.12%	9,253 $207,000
Q4 2017 Feb 09, 2018	BUY	$12.52 - $17.82 $2,416 - $3,439	193 Added 2.02%	9,752 $124,000
Q3 2017 Nov 09, 2017	BUY	$11.17 - $16.99 $106,774 - $162,407	9,559	9,559 $149,000

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account